摘要
寄生虫病细胞工程学免疫防治研究,经历了20余a,首先在中国获得成功。在国家 九五"两项重大科技攻关项目支持下,建立了猪囊尾蚴CC-97细胞系,研制成功了猪囊尾蚴细胞疫苗;2000年以来,在国家自然科学基金等基金支持下,日本血吸虫幼虫———毛蚴、尾蚴和成虫细胞体外培养相继获得成功,开创了血吸虫病细胞工程学免疫防治的新局面。
After more than twenty years' study, researches on prevention and treatment of parasitoses by immunity of cytological engineering technique first succeeded in China. Under the supports of two item Grants(No. 96005020206;No.960050205)from the Key Science and Technique Project in National '9·5' of China, a CC97 immune cell line of Cysticercus cellulosae and its cell vaccine were established.Since 2000,under the supports of Fund of National Natural Science of China (No.30170840), and Fund of Prevention and Treatment of Major Disease of Agricultural Ministry (No.200114704), the Schistosoma japonicum cells were successful in in vitro cultivations,which derived from miracidia, cercariae and adult of Schistosoma japonicum. Thus,a new prospect in prevention and treatment of Schistosomaisis has been opened up by immunity of cytological engineering technique.
出处
《天津农学院学报》
CAS
2002年第4期1-4,共4页
Journal of Tianjin Agricultural University
基金
国家 九五"两项重大科技攻关项目(96-005-02-02-06
96-005-02-05)
国家自然科学基金项目"血吸虫细胞培养与建系研究"(30170840)
农业部重大疾病防治基金项目"血吸虫病防治方法与方案研究"(200114704)
关键词
免疫防治
寄生虫病
细胞工程学
猪囊尾蚴细胞系
细胞疫苗
日本血吸虫
parasitosis
cytological engineering technique
cysticercosis
cell line of Cysticercus cellulosae
cell vaccine of Cysticercus cellulosae
cells of Schistosoma japonicum
